Stay updated on PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial

Sign up to get notified when there's something new on the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The clinical trial record for the PROCEED study is displayed, describing its pembrolizumab and chemoradiation treatment plan, participant criteria, measured outcomes, and completed status.
    Difference
    44%
    Check dated 2026-11-08T14:59:36.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T16:13:52.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide NIH announcement banner was added with links to transition updates and a notice about the agency’s shift from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-25T16:49:35.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T22:30:31.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-11T22:28:55.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, indicating restricted access to the study record. As a result, only basic site chrome is visible while the main study details are inaccessible.
    Difference
    18%
    Check dated 2026-09-20T22:48:23.000Z thumbnail image

Stay in the know with updates to PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page.